U.S. Alfacalcidol Market Trends 2034: Advancements in Vitamin D-Based Therapies and Drug Formulations The US is anticipated to remain an important market for alfacalcidol, owing to its large population of patients with chronic conditions and strong pharmaceutical infrastructure. Greater emphasis on the diagnosis and management of chronic kidney disease and mineral and bone disorders is boosting demand for vitamin D analogs. Increased healthcare investment and expanding access to specialized treatments are further supporting market growth. Read More - https://www.theinsightpartners.com/reports/alfacalcidol-market